{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:57:46Z","timestamp":1794643066998,"version":"4.9.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1097\/pas.0000000000000297","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T16:40:34Z","timestamp":1405442434000},"page":"1715-1723","source":"Crossref","is-referenced-by-count":143,"title":["Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) Is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated With PDCD1LG2 Copy Gain"],"prefix":"10.1097","volume":"38","author":[{"given":"Min","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaretha G.M.","family":"Roemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjoern","family":"Chapuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine S.","family":"Pinkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Shipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon J.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Rodig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-17-20210131","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","article-title":". Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (groupe detude des lymphomes de ladulte) study.","volume":"20","author":"Cazals-Hatem","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R4-17-20210131","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571","article-title":". Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene.","volume":"87","author":"Joos","year":"1996","journal-title":"Blood"},{"key":"R5-17-20210131","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1098-2264(2001)9999:9999<::AID-GCC1105>3.0.CO;2-I","article-title":". Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): Comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line.","volume":"30","author":"Bentz","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"R6-17-20210131","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0046-8177(99)90273-3","article-title":". Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases.","volume":"30","author":"Paulli","year":"1999","journal-title":"Hum Pathol"},{"key":"R7-17-20210131","first-page":"229","article-title":"Joos S, et al..","volume":"3","author":"Barth","year":"2002","journal-title":"Mediastinal (thymic) large B-cell lymphoma: where do we stand Lancet Oncol"},{"key":"R8-17-20210131","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/01.MP.0000032534.81894.B3","article-title":". MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas.","volume":"15","author":"Copie-Bergman","year":"2002","journal-title":"Mod Pathol"},{"key":"R9-17-20210131","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1182\/blood.V94.10.3567.422k06_3567_3575","article-title":". The MAL gene is expressed in primary mediastinal large B-cell lymphoma.","volume":"94","author":"Copie-Bergman","year":"1999","journal-title":"Blood"},{"key":"R10-17-20210131","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.pas.0000213334.40358.0e","article-title":". Expression of TRAF1 and nuclear c-rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.","volume":"31","author":"Rodig","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R11-17-20210131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1066896909331994","article-title":". The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma.","volume":"18","author":"Salama","year":"2010","journal-title":"Int J Surg Pathol"},{"key":"R12-17-20210131","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/modpathol.2012.129","article-title":"Utility of CD200 immunostaining in the diagnosis of primary mediastinal large B cell lymphoma: comparison with MAL, CD23, and other markers.","volume":"25","author":"Dorfman","year":"2012","journal-title":"Mod Pathol"},{"key":"R13-17-20210131","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":". PD-1 and its ligands in tolerance and immunity.","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"R14-17-20210131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":". PD-L2 is a second ligand for PD-1 and inhibits T cell activation.","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat Immunol"},{"key":"R15-17-20210131","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance.","volume":"5","author":"Zou","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"R16-17-20210131","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":". Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"R17-17-20210131","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":". Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"R18-17-20210131","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":". Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"R19-17-20210131","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood-2009-12-257345","article-title":". Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome.","volume":"116","author":"Steidl","year":"2010","journal-title":"Blood"},{"key":"R20-17-20210131","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":". Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"R21-17-20210131","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":". PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies.","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R22-17-20210131","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ni1554","article-title":". CD160 inhibits activation of human CD4 T cells through interaction with herpesvirus entry mediator.","volume":"9","author":"Cai","year":"2008","journal-title":"Nat Immunol"},{"key":"R23-17-20210131","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/PAS.0b013e31822bd476","article-title":". Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B-cell lymphoma distinguishes these tumor types from morphologically and phenotypically similar lymphomas.","volume":"35","author":"Kondratiev","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R24-17-20210131","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ccr.2012.07.014","article-title":". Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma.","volume":"22","author":"Monti","year":"2012","journal-title":"Cancer Cell"},{"key":"R25-17-20210131","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method.","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"R26-17-20210131","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ccr.2010.11.013","article-title":". Cooperative epigenetic modulation by cancer amplicon genes.","volume":"18","author":"Rui","year":"2010","journal-title":"Cancer Cell"},{"key":"R28-17-20210131","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":". Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med"},{"key":"R29-17-20210131","first-page":"1258","article-title":". Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.","volume":"87","author":"Zinzani","year":"2002","journal-title":"Haematologica"},{"key":"R30-17-20210131","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1158\/1078-0432.CCR-13-3007","article-title":". Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo.","volume":"20","author":"Hao","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R31-17-20210131","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood-2003-10-3545","article-title":". Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.","volume":"104","author":"Guiter","year":"2004","journal-title":"Blood"},{"key":"R32-17-20210131","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/modpathol.3800440","article-title":". Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas.","volume":"18","author":"Zamo","year":"2005","journal-title":"Mod Pathol"},{"key":"R33-17-20210131","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":". Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma.","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"key":"R34-17-20210131","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":". MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"key":"R35-17-20210131","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/0008-5472.CAN-12-2384","article-title":". Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.","volume":"73","author":"Lyford-Pike","year":"2013","journal-title":"Cancer Res"},{"key":"R36-17-20210131","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1158\/1078-0432.CCR-12-3314","article-title":". Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages.","volume":"19","author":"Bloch","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R37-17-20210131","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","article-title":". Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: Implications for targeted therapy.","volume":"18","author":"Green","year":"2012","journal-title":"Clin Cancer Res"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:43:51Z","timestamp":1620967431000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201412000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000297","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}